Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis-Reference-Cited by-同舟云学术

Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis

Published:2021 Issue: Volume: Page:87-105
ISSN:0065-2598
Container-title:Advances in Experimental Medicine and Biology
language:
Short-container-title:

Author:

Atabati Hadi,Yazdanpanah Esmaeil,Mortazavi Hamed,bajestani Saeed Gharibian,Raoofi Amir,Esmaeili Seyed-Alireza,Khaledi Azad,Saburi Ehsan,Afshari Jalil Tavakol,Sathyapalan Thozhukat,Moghaddam Abbas Shapouri,Sahebkar Amirhossein

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-030-55035-6_6

Reference139 articles.

1. Zhang X, Tao Y, Chopra M, Dujmovic-Basuroski I, Jin J, Tang Y, Drulovic J et al (2015) IL-11 induces Th17 cell responses in patients with early relapsing-remitting multiple sclerosis. J Immunol 194(11):5139. https://doi.org/10.4049/jimmunol.1401680

2. Fernando V, Omura S, Sato F, Kawai E, Martinez NE, Elliott SF et al (2014) Regulation of an autoimmune model for multiple sclerosis in Th2-biased GATA3 transgenic mice. Int J Mol Sci 15(2):1700–1718

3. Evans E, Piccio L, Cross AH (2018) Use of vitamins and dietary supplements by patients with multiple sclerosis: a review. JAMA Neurol 75(8):1013–1021

4. Koriem KMM (2016) Multiple sclerosis: new insights and trends. Asian Pac J Trop Biomed 6(5):429–440

5. Lin R, Charlesworth J, van der Mei I, Taylor BV (2012) The genetics of multiple sclerosis. Pract Neurol 12(5):279–288

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Procalcitonin in inflammatory bowel disease: A diagnostic or prognostic marker;Pathology - Research and Practice;2024-10

2. The Characterization of the Th1/Th2 Ratio in Multiple Sclerosis Patients and its Response to a Dietary Supplement Regimen;Journal of Dietary Supplements;2024-08-14

3. The Role of Intestinal Microbiota and Probiotics Supplementation in Multiple Sclerosis Management;Neuroscience;2024-07

4. Therapeutic potential of lipid-lowering probiotics on the atherosclerosis development;European Journal of Pharmacology;2024-05

5. Tolerogenic probiotics Lactobacillus delbrueckii and Lactobacillus rhamnosus promote anti‐inflammatory profile of macrophages‐derived monocytes of newly diagnosed patients with systemic lupus erythematosus;Cell Biochemistry and Function;2024-03